Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "financial-performance"

66 News Found

Sanofi Consumer Healthcare reports 33% revenue growth in Q1 FY26; PAT rises 36%
Healthcare | April 29, 2026

Sanofi Consumer Healthcare reports 33% revenue growth in Q1 FY26; PAT rises 36%

Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market


Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
Startup | April 28, 2026

Orange Health records Rs 138 crore revenue at 65% annual growth in FY26

The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities


Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
Supply Chain | April 17, 2026

Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion

The company allocated €56 million to research and development for next-generation line solutions


Merck delivers resilient 2025 performance despite global headwinds
News | March 06, 2026

Merck delivers resilient 2025 performance despite global headwinds

Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results


Sanofi Consumer Healthcare India reports robust Q4 and FY’25 growth
News | February 26, 2026

Sanofi Consumer Healthcare India reports robust Q4 and FY’25 growth

For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales


BNB Plus’ Biopharma subsidiary LineaRx lands major LineaDNA orders
News | February 25, 2026

BNB Plus’ Biopharma subsidiary LineaRx lands major LineaDNA orders

The announcement follows a record-setting $1.2 million accelerated LineaDNA order


Akums surges in Q3 FY26 with 15% revenue jump, bags key EU & UK nods
News | February 14, 2026

Akums surges in Q3 FY26 with 15% revenue jump, bags key EU & UK nods

Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore


Wockhardt reports strong Q3 growth: revenue up 22%, EBITDA surges 72%
News | February 11, 2026

Wockhardt reports strong Q3 growth: revenue up 22%, EBITDA surges 72%

The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year


Gland Pharma reports robust Q3 FY26 results: revenue up 22%, adj. PAT soars 37%
News | January 30, 2026

Gland Pharma reports robust Q3 FY26 results: revenue up 22%, adj. PAT soars 37%

The base Gland business posted ?11,790 million in revenue, up 16% YoY